Researchers to test gene therapy for rare diseases with a new FDA trial protocol

Earlier this year, researchers at Children’s Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup